Ingevity Co. (NYSE:NGVT) is Vision One Management Partners LP's 6th Largest Position

Vision One Management Partners LP boosted its holdings in shares of Ingevity Co. (NYSE:NGVT - Free Report) by 265.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 410,678 shares of the company's stock after purchasing an additional 298,157 shares during the quarter. Ingevity comprises 9.0% of Vision One Management Partners LP's portfolio, making the stock its 6th biggest holding. Vision One Management Partners LP owned 1.13% of Ingevity worth $16,735,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. KBC Group NV increased its stake in Ingevity by 27.5% in the 4th quarter. KBC Group NV now owns 2,007 shares of the company's stock worth $82,000 after acquiring an additional 433 shares during the last quarter. Empowered Funds LLC purchased a new position in shares of Ingevity in the 4th quarter worth approximately $187,000. O Shaughnessy Asset Management LLC purchased a new position in shares of Ingevity in the 4th quarter worth approximately $214,000. Teacher Retirement System of Texas purchased a new position in shares of Ingevity in the 4th quarter worth approximately $237,000. Finally, Hennion & Walsh Asset Management Inc. purchased a new position in shares of Ingevity in the 4th quarter worth approximately $239,000. Institutional investors own 91.59% of the company's stock.

Ingevity Stock Down 0.6%

Shares of NGVT stock traded down $0.27 during mid-day trading on Friday, hitting $41.04. The stock had a trading volume of 246,617 shares, compared to its average volume of 280,271. Ingevity Co. has a 12-month low of $28.49 and a 12-month high of $51.67. The firm has a market capitalization of $1.50 billion, a P/E ratio of -3.47 and a beta of 1.31. The firm's 50-day moving average is $36.94 and its two-hundred day moving average is $42.14. The company has a debt-to-equity ratio of 6.86, a current ratio of 1.87 and a quick ratio of 1.04.

Ingevity (NYSE:NGVT - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.74 by $0.25. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. The business had revenue of $284.00 million during the quarter, compared to analysts' expectations of $299.13 million. During the same period in the prior year, the business earned $0.47 EPS. The business's revenue for the quarter was down 16.5% compared to the same quarter last year. On average, analysts predict that Ingevity Co. will post 4.45 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on NGVT. Wall Street Zen cut Ingevity from a "buy" rating to a "hold" rating in a report on Saturday, April 12th. Wells Fargo & Company boosted their price objective on Ingevity from $32.00 to $38.00 and gave the company an "equal weight" rating in a report on Wednesday, May 7th. Finally, BMO Capital Markets upgraded Ingevity from a "market perform" rating to an "outperform" rating and boosted their price objective for the company from $62.00 to $65.00 in a report on Wednesday, February 26th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $52.75.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.